← Eichor
Study identifier: NCT05415111 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Adjunctive Effect of Soft Tissue Augmentation Procedures of Moderate-severe Peri-implantitis

Condition: Peri-Implantitis  ·  Sponsor: Nadja Naenni

PhaseNA
Planned participants120
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

The key objective of the study is to compare the effects of soft tissue augmentation using a volume stable collagen matrix or autogenous connective tissue graft or no soft tissue augmentation in addition to bone grafting/implantoplasty in patients who undergo surgical therapy of peri-implantitis with respect to clinical resolution of the infection.

This description comes directly from the study's public registry record.

Talk to the study team

Jolanta Boruta  ·  +41446343260  ·  jolanta.boruta@zzm.uzh.ch

Silvia Rasi, Dr.  ·  +4144643365  ·  silvia.rasi@zzm.uzh.ch

Always discuss trial participation with your own doctor first.

Locations (3)

Department of Oral Surgery and Implantology, Centre for Dentistry and Oral Medicine (Carolinum), Johann Wolfgang Goethe-University FrankfurtFrankfurt, GermanyNot Yet Recruiting
National Dental Centre SingaporeSingapore, SingaporeNot Yet Recruiting
Clinic of Reconstructive Dentistry, Center of Dental Medicine University of ZurichZurich, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05415111